IKK2-IN-9

CAS No. 1266240-89-4

IKK2-IN-9( —— )

Catalog No. M11120 CAS No. 1266240-89-4

IKK2-IN-9 is a potent, selective and orally active IKK2 inhibitor with IC50 of 19 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    IKK2-IN-9
  • Note
    Research use only, not for human use.
  • Brief Description
    IKK2-IN-9 is a potent, selective and orally active IKK2 inhibitor with IC50 of 19 nM.
  • Description
    IKK2-IN-9 is a potent, selective and orally active IKK2 inhibitor with IC50 of 19 nM, displays 20-fold selectivity over IKK1 (IC50=420 nM); inhibits lipopolysaccharide (LPS) induced TNFα production in human PBMCs with IC50 of 0.22 uM; dose-dependently inhibist the TNF-α response in murine model of acute inflammation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    IκB kinase (IKK)
  • Recptor
    IκB kinase (IKK)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1266240-89-4
  • Formula Weight
    394.497
  • Molecular Formula
    C20H22N6OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (S)-N-(1-(3-(5-(ethylamino)-8-methyl-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Dyckman AJ, et al. Bioorg Med Chem Lett. 2011 Jan 1;21(1):383-6.
molnova catalog
related products
  • AZD3264

    A novel IkB-kinase IKK2 inhibitor for treatment of inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.

  • IKK16

    IKK16 is a potent, selective inhibitor of IκB kinase (IKK) with IC50 of 40, 70 and 200 nM for IKKβ, IKK complex and IKKα respectively.

  • MRT67307 HCl

    MRT67307 is a kinase inhibitor of TBK1 MARK1-4 IKKε and NUAK1 (IC50: 19 27-52 160 and 230 nM respectively).